JP2021522241A5 - - Google Patents
Info
- Publication number
- JP2021522241A5 JP2021522241A5 JP2020559390A JP2020559390A JP2021522241A5 JP 2021522241 A5 JP2021522241 A5 JP 2021522241A5 JP 2020559390 A JP2020559390 A JP 2020559390A JP 2020559390 A JP2020559390 A JP 2020559390A JP 2021522241 A5 JP2021522241 A5 JP 2021522241A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- approximately
- subject
- administration
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024066665A JP2024096933A (ja) | 2018-04-25 | 2024-04-17 | 抗ｏｓｍｒβ抗体の送達による皮膚疾患又は障害の治療 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662607P | 2018-04-25 | 2018-04-25 | |
| US62/662,607 | 2018-04-25 | ||
| US201862718324P | 2018-08-13 | 2018-08-13 | |
| US62/718,324 | 2018-08-13 | ||
| US201862765033P | 2018-08-16 | 2018-08-16 | |
| US62/765,033 | 2018-08-16 | ||
| US201862731618P | 2018-09-14 | 2018-09-14 | |
| US62/731,618 | 2018-09-14 | ||
| US201862757047P | 2018-11-07 | 2018-11-07 | |
| US62/757,047 | 2018-11-07 | ||
| US201862775350P | 2018-12-04 | 2018-12-04 | |
| US62/775,350 | 2018-12-04 | ||
| US201962789434P | 2019-01-07 | 2019-01-07 | |
| US62/789,434 | 2019-01-07 | ||
| US201962794356P | 2019-01-18 | 2019-01-18 | |
| US62/794,356 | 2019-01-18 | ||
| PCT/IB2019/000619 WO2019229525A2 (en) | 2018-04-25 | 2019-04-25 | TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRβ ANTIBODY |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024066665A Division JP2024096933A (ja) | 2018-04-25 | 2024-04-17 | 抗ｏｓｍｒβ抗体の送達による皮膚疾患又は障害の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522241A JP2021522241A (ja) | 2021-08-30 |
| JP2021522241A5 true JP2021522241A5 (enExample) | 2022-05-06 |
Family
ID=68234020
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559390A Withdrawn JP2021522241A (ja) | 2018-04-25 | 2019-04-25 | 抗ｏｓｍｒβ抗体の送達による皮膚疾患又は障害の治療 |
| JP2024066665A Pending JP2024096933A (ja) | 2018-04-25 | 2024-04-17 | 抗ｏｓｍｒβ抗体の送達による皮膚疾患又は障害の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024066665A Pending JP2024096933A (ja) | 2018-04-25 | 2024-04-17 | 抗ｏｓｍｒβ抗体の送達による皮膚疾患又は障害の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20210054085A1 (enExample) |
| EP (1) | EP3784347A2 (enExample) |
| JP (2) | JP2021522241A (enExample) |
| KR (2) | KR102849806B1 (enExample) |
| CN (2) | CN121818914A (enExample) |
| AU (2) | AU2019276779A1 (enExample) |
| BR (1) | BR112020021739A2 (enExample) |
| CA (1) | CA3096582A1 (enExample) |
| IL (1) | IL326629A (enExample) |
| MX (2) | MX2020011172A (enExample) |
| SG (1) | SG11202010034WA (enExample) |
| WO (1) | WO2019229525A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230391878A1 (en) * | 2020-09-01 | 2023-12-07 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for prevention and/or treatment of dialysis pruritus containing il-31 antagonist as active ingredient |
| TWI871349B (zh) * | 2020-09-01 | 2025-02-01 | 日商中外製藥股份有限公司 | 含有il-31拮抗劑作為有效成分之透析搔癢症的預防用及/或治療用醫藥組合物 |
| TWI904261B (zh) | 2020-10-19 | 2025-11-11 | 美商碩騰服務公司 | 犬及貓抑瘤素Ｍ受體β之抗體及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006088955A2 (en) * | 2005-02-14 | 2006-08-24 | Zymogenetics, Inc. | Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| AU2012202218B2 (en) * | 2005-02-14 | 2014-05-22 | National Jewish Medical And Research Center | Methods Of Treating Diseases Which Are Mediated By Cutaneous Lymphocyte Antigen Positive Cells |
| US9475876B2 (en) * | 2012-05-11 | 2016-10-25 | Wakayama Medical University | Anti oncostatin M receptor beta antibody used for treating atopic dermatitis |
| HUE056580T2 (hu) * | 2013-05-30 | 2022-02-28 | Kiniksa Pharmaceuticals Ltd | Onkosztatin-M-receptor antigénjét kötõ fehérjék |
| TWI633891B (zh) * | 2013-06-04 | 2018-09-01 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法 |
| WO2016120625A1 (en) * | 2015-01-29 | 2016-08-04 | Isis Innovation Limited | Biomarker |
| JP5954916B1 (ja) * | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
-
2019
- 2019-04-25 BR BR112020021739-5A patent/BR112020021739A2/pt unknown
- 2019-04-25 KR KR1020207033800A patent/KR102849806B1/ko active Active
- 2019-04-25 EP EP19786854.0A patent/EP3784347A2/en active Pending
- 2019-04-25 US US17/050,261 patent/US20210054085A1/en not_active Abandoned
- 2019-04-25 WO PCT/IB2019/000619 patent/WO2019229525A2/en not_active Ceased
- 2019-04-25 MX MX2020011172A patent/MX2020011172A/es unknown
- 2019-04-25 JP JP2020559390A patent/JP2021522241A/ja not_active Withdrawn
- 2019-04-25 KR KR1020257027582A patent/KR20250127348A/ko active Pending
- 2019-04-25 IL IL326629A patent/IL326629A/en unknown
- 2019-04-25 AU AU2019276779A patent/AU2019276779A1/en not_active Abandoned
- 2019-04-25 CN CN202510495862.4A patent/CN121818914A/zh active Pending
- 2019-04-25 SG SG11202010034WA patent/SG11202010034WA/en unknown
- 2019-04-25 CA CA3096582A patent/CA3096582A1/en active Pending
- 2019-04-25 CN CN201980039355.2A patent/CN112533675A/zh active Pending
-
2020
- 2020-10-22 MX MX2025006542A patent/MX2025006542A/es unknown
-
2023
- 2023-03-30 US US18/193,393 patent/US20240101690A1/en not_active Abandoned
-
2024
- 2024-04-17 JP JP2024066665A patent/JP2024096933A/ja active Pending
- 2024-10-04 US US18/907,052 patent/US20250236676A1/en active Pending
-
2026
- 2026-03-16 AU AU2026201985A patent/AU2026201985A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240417455A1 (en) | Treatment for rheumatoid arthritis | |
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| CN104010656B (zh) | 使用免疫球蛋白和c1-抑制剂的联合疗法 | |
| JP2025172841A5 (enExample) | ||
| JP2023548858A5 (enExample) | ||
| JP2021523188A5 (enExample) | ||
| JP2022543612A5 (enExample) | ||
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2021522241A5 (enExample) | ||
| JP2020535149A5 (enExample) | ||
| JP2022121658A (ja) | アミロイドーシスを処置するための組成物 | |
| Robak et al. | Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura | |
| CN107849128A (zh) | 瘙痒治疗 | |
| JP2023531722A5 (enExample) | ||
| JP2023514567A5 (enExample) | ||
| CA3176673A1 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of respiratory disease | |
| TW202114734A (zh) | Il-17拮抗劑治療自身免疫疾病的方法 | |
| US20130267484A1 (en) | Treatment of rheumatoid arthritis with masitinib | |
| Nowak et al. | Reviewing the current treatment approaches for bullous pemphigoid–analysis of literature | |
| CA2884124C (en) | Treatment for rheumatoid arthritis | |
| JP2025512860A5 (enExample) | ||
| JP2023553702A5 (enExample) | ||
| TH2001001181A (th) | วิธีการสำหรับการบำบัดโรคที่เกี่ยวข้องกับ-tnf | |
| NZ773889B2 (en) | Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody | |
| NZ773889A (en) | Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody |